#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	743.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	936	C	858	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	743.9	0	HET	.	.	.	C1525T,A	.	1525	1525	C	1785	1785	C	784	C,T,A	542,136,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2128	743.9	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1672	1672	T	894	TGGGGG,TGGGGGG	434,356	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3351	845.7	0	.	n	.	0	T695C	SNP	695	695	T	922	922	C	883	C,T	800,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3351	845.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1865	1865	G	931	G	859	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3351	845.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2198	2198	C	990	C,A	895,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3351	845.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2272	2272	A	915	A	847	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3351	845.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2824	2824	C	903	C,T	835,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2028	folP	855	855	100.0	folP.l15.c30.ctg.1	1536	131.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1051	1053	AGC	214;212;211	A;G;C	193;192;189	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5582	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	166.4	1	SNP	p	S91F	1	.	.	271	273	TTC	526	528	TTC	180;179;182	T;T;C	166;165;165	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5582	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	166.4	1	SNP	p	G95N	0	.	.	283	285	GGC	538	540	GGC	178;173;172	G;G;C	163;161;159	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5582	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3344	166.4	1	SNP	p	D95G	1	.	.	283	285	GGC	538	540	GGC	178;173;172	G;G;C	163;161;159	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1650	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1237	132.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	829	831	TTG	191;190;193	T;T;G	177;176;178	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1650	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1237	132.7	1	SNP	p	G45D	0	.	.	133	135	GGC	412	414	GGC	186;185;190	G;G;C	177;175;176	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	822	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	869	94.1	0	.	n	.	0	A197.	DEL	197	197	A	485	485	A	191	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5686	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	198.5	1	SNP	p	D86N	0	.	.	256	258	GAC	607	609	GAC	254;253;256	G;A;C	229;228;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5686	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	198.5	1	SNP	p	R87W	0	.	.	259	261	CGT	610	612	CGT	253;252;252	C;G;T	231;230;226	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5686	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	198.5	1	SNP	p	R87I	0	.	.	259	261	CGT	610	612	CGT	253;252;252	C;G;T	231;230;226	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5686	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	198.5	1	SNP	p	S87R	1	.	.	259	261	CGT	610	612	CGT	253;252;252	C;G;T	231;230;226	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5686	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	198.5	1	SNP	p	S88P	0	.	.	262	264	TCC	613	615	TCC	252;256;256	T;C;C	232;235;234	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4408	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2424	180.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1445	1447	GGC	204;201;197	G;G;C	186;180;177	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1211	1213	GCA	234;236;234	G;C;A	216;217;219	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1214	1216	ATC	235;236;233	A;T;C	218;219;217	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1226	1228	GTG	224;223;225	G;T;G	205;202;202	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1226	1228	GTG	224;223;225	G;T;G	205;202;202	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1730	1732	ACC	229;227;227	A;C;C,T	206;210;208,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1784	1786	GCG	216;217;217	G;C;G	184;169;180	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1784	1786	GCG	216;217;217	G;C;G	184;169;180	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1907	1909	AGC	193;191;193	A,G;G,A;C	168,1;166,1;167	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1916	1918	GGC	187;183;182	G;G;C,T	160;157;158,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4308	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2307	185.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1934	1936	CCG	156;160;156	C,G;C;G	117,2;118;118	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5904	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3039	193.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1625	1627	CCG	235;236;238	C,T;C;G	209,1;215;206	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2308	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1826	125.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	595	595	C	158	C	145	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	384	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	509	35.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	359	361	ACG	91;90;87	A;C;G	81;80;76	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	384	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	509	35.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	401	403	CAA	46;47;45	C;A;A	40;40;39	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	384	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	509	35.6	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	407	409	TAC	33;30;25	T;A;C	30;26;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	497	499	GAA	269;269;266	G;A;A	249;252;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	785	787	GAT	269;271;272	G;A;T	241;243;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	908	910	TCA	256;259;255	T;C;A	237;242;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	Q214R	NONSYN	640	642	CAA	1025	1027	CGA	265;259;259	C;G,A;A	244;241,1;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1037	1039	GTC	251;249;250	G;T;C	234;231;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1049	1051	TCT	257;255;256	T;C;T	237;239;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	A323V	NONSYN	967	969	GCC	1352	1354	GTC	213;215;213	G;T;C	199;199;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1367	1369	GCA	225;227;231	G;C;A	207;209;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	1	SNP	p	G120K	1	.	.	358	360	AAG	743	745	AAG	257;258;256	A;A;G	233;232;231	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	1	SNP	p	D121N	0	.	.	361	363	GAC	746	748	GAC	256;255;255	G;A;C	227;231;232	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3068	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1569	194.7	1	SNP	p	A121D	1	.	.	361	363	GAC	746	748	GAC	256;255;255	G;A;C	227;231;232	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11996	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4745	251.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1236	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	989	124.2	1	SNP	p	V57M	1	.	.	169	171	ATG	500	502	ATG	280;283;285	A;T;G	260;261;263	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
